Adrenas Therapeutics Inc
2 clinical trials · Sponsor
◉ Watch Adrenas Therapeutics Inc
| Record | Firm | Date |
|---|---|---|
| A Study to Determine Eligibility for CAH-301 (A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH) [NCT04783181]) (NCT05101902) | Adrenas Therapeutics Inc | 2021-07-01 |
| A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH) (NCT04783181) | Adrenas Therapeutics Inc | 2021-07-01 |
Track Adrenas Therapeutics Inc automatically
Every clearance here is in the API, with alerts when new ones post.